Search results
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 3 days agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 3 days agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied...
Pfizer profits drop on lower Covid-19 product sales
AFP via Yahoo Finance· 3 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
US FDA grants full approval for Pfizer's cervical cancer drug
Reuters· 5 days ago, opens new tab drug for treating cervical cancer patients whose disease had progressed on or after...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 4 days agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 3 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
What's Going With Pfizer Stock On Wednesday? - Pfizer (NYSE:PFE)
Benzinga· 3 days agoOn Wednesday, Pfizer Inc. PFE reported first-quarter adjusted EPS of $0.82, down 33% year over year,...
Pfizer Stock Rises as Outlook Raised After Earnings Beat
Barrons.com· 3 days agoPfizer reports first-quarter adjusted earnings of 82 cents a share on revenue of $14.88 billion.Read...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 3 days agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 3 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...